han si liang, PhD

Resident doctor
The first affiliated hospital of soochow university, China (People's Republic)

Presentation(s):

• 46 - Inhibiting the FGFR4 Signaling Pathway Suppresses Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma After Transarterial Chemoembolization

  Monday, March 31, 2025
  12:10 PM – 1:10 PM CT

• Lenvatinib Ameliorates the Immunosuppressive Microenvironment of Hepatocellular Carcinoma after Transarterial Chemoembolization

  Wednesday, April 2, 2025
  11:06 AM – 11:15 AM CT